Galera Therapeutics, Inc(NASDAQ:GRTX) 
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimet...
Website: http://www.galeratx.com
Full Time Employees: 32
CEO: J. Mel Sorensen
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 0.13
H 0.13
L 0.12
C 0.13
V 98,447
10EMA 0.13
20EMA 0.13
60EMA 0.13
120EMA 0.13
250EMA 0.13